PPD, Inc. has opened offices in Athens, Greece, and Seattle, WA, in an effort to expand its global footprint for clinical development services. Both offices serve as hubs for previously regional-based employees in providing development services for Phase II-IV studies in key therapeutic areas. The office in Athens focuses on patient recruitment, clinical monitoring and regulatory support and the Seattle office houses clinical monitoring and project management teams.
"The new offices enable us to address the organic growth of our business driven by client needs for Phase II-IV services as well as enhance support for our employees located in these areas," said Fred Eshelman, chief executive officer of PPD. "We plan continued investment in infrastructure, systems and people to align with the global research needs of our clients."
Magazine
